- About
-
The Global ETD Search service is a free service for researchers
to find electronic theses and dissertations. This service is
provided by the
Networked Digital Library of Theses and Dissertations.
Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
Search results
Showing 1 to 10 of 75 (0.094 seconds)Spelling suggestions: "subject:"tumor barkers/biological"" "subject:"tumor arkers/biological""
| 1 |
Protein expression in prostate cancer /Lexander, Helena, January 2006 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2006. / Härtill 4 uppsatser.
|
| 2 |
Cancer proteomics method development for mass spectrometry based analysis of clinical materials /Pernemalm, Maria, January 2009 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2009. / Härtill 5 uppsatser.
|
| 3 |
Pheochromocytoma and abdominal paraganglioma : clinical and genetic aspects /Edström Elder, Elisabeth, January 2002 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2002. / Härtill 5 uppsatser.
|
| 4 |
On prognostic and treatment predictive factors in early stage breast cancer /Billgren, Ann-Marie, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2002. / Härtill 5 uppsatser.
|
| 5 |
Colon cancer : disease related proteins in tumor tissue and serum /Roblick, Uwe Johannes, January 2004 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 6 uppsatser.
|
| 6 |
Mesothelial differentiation, mesothelioma and tumor markers in serous cavities /Gulyás, Miklós, January 2003 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 5 uppsatser.
|
| 7 |
Targeting nanoparticles to tumor vasculatureMarconescu, Andrei January 2008 (has links)
Dissertation (Ph.D.) -- University of Texas Southwestern Medical Center at Dallas, 2008. / Vita. Bibliography: p. 142-159.
|
| 8 |
Tumour marker CA-50 in pancreatic cancerPålsson, Birger. January 1993 (has links)
Thesis (doctoral)--Lund University, 1993. / Added t.p. with thesis statement inserted.
|
| 9 |
Tumour marker CA-50 in pancreatic cancerPålsson, Birger. January 1993 (has links)
Thesis (doctoral)--Lund University, 1993. / Added t.p. with thesis statement inserted.
|
| 10 |
Correlação entre a expressão de VEGF e a sobrevida no osteossarcoma / Correlation between the expression of VEGF and survival in osteosarcomaBaptista, André Mathias 25 August 2010 (has links)
Foram analisados 50 casos de osteossarcoma não metastáticos das extremidades tratados no Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo entre 1986 e 2006 no que se refere à expressão de VEGF. Dezenove pacientes do sexo feminino e 31 do sexo masculino foram a casuística do trabalho. A idade variou de 5 a 28 anos (média de 16 anos) e o seguimento dos pacientes variou de 25 a 167 meses (média de 60,6 meses). As variáveis estudadas foram idade, sexo, localização anatômica, tipo de cirurgia, margens cirúrgicas, tamanho do tumor, necrose pós QT, recidiva local, metástase pulmonar e óbito. Trinta e seis pacientes apresentaram expressão de VEGF menor ou igual a 30% das células tumorais (baixa expressão), ao passo que os 14 restantes apresentaram expressão acima de 30% das células (alta expressão). Dos 36 pacientes com baixa expressão de VEGF, nove evoluíram com metástases pulmonares, dos quais quatro foram a óbito (11,1%). Dentre os 14 casos com alta expressão de VEGF, seis evoluíram com metástases pulmonares e três foram a óbito (21,4%). Porém, não houve correlação estatisticamente significante entre a expressão de VEGF e qualquer das variáveis estudadas / Fifty cases of nonmetastatic osteosarcoma of the extremities treated between 1986 and 2006 at the Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo were evaluated regarding the expression of VEGF. There were 19 females and 31 males. The mean age was 16 years (528) and the mean followup was 60,6 months (25 167). The variables studied were age, gender, anatomic location, type of surgery, surgical margins, tumor size, post chemotherapy necrosis, local recurrence, pulmonary metastasis and death. Thirtysix patients showed VEGF expression equal or under 30% of the cells (low expression), as the remaining 14 cases had VEGF expression above 30% (high expression). Among the 36 patients with low VEGF expression, nine developed pulmonary metastasis and four died (11,1%). Among the 14 patients with high VEGF expression, six developed pulmonary metastasis and three died (21,4%). There was no statistical significant correlation between the VEGF expression and any of the variables studied
|
Page generated in 0.1004 seconds